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Liquid-Chromatographic
Assay of Cefamandole in Serum, Urine, and Dialysis Fluid
Maria Bliss and Michael Mayersohn1
We describe a "high-performance" liquid-chromatographic assay for quantifying cefamandole in biological fluids from patients with renal impairment. Serum samples are deproteinized with acetonitrile, then extracted 
NJ 07014).
Standard s and samples.
Aqueous 10 g/L standards of cefamandole lithium were prepared and portions were frozen at -4 #{176}C. They were thawed on the day they were used.
Working standards with concentrations ranging from 25 to 500 mg/L were prepared by diluting with doubly distilled water; we added 20 iL of each to 480-giL samples of drugfree serum, "used" dialysis fluid, or 10-fold diluted urine to at each concentration for each fluid-to assess intra-and interassay reproducibility, and also storage stability. We assayed cefamandole in aliquots stored frozen for 60 days to determine sample storage stability. time for urine and dialysis fluid was 72 h. We collected samples from each of the six subjects before the administration of cefamandole, to assess possible interference, especially from co-administered medications.
Results

and Discussion
Our goal was to develop a liquid-chromatographic assay for cefamandole in samples from renally impaired subjects that would have the necessary sensitivity, selectivity, and reproducibility for pharmacokinetic studies. and fluid from the same subject after taldng cefamandole ( io , 0.667; 0.768 x iO , -0.006; 1.088 x iO , 0.424; and   1.040 x io-, -0.170, 
